Literature DB >> 9065488

Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells.

N B Mercuri1, M Scarponi, A Bonci, A Siniscalchi, G Bernardi.   

Abstract

The way monoamine oxidase (MAO) modulates the depression of the firing rate and the hyperpolarization of the membrane caused by dopamine (DA) on rat midbrain dopaminergic cells was investigated by means of intracellular recordings in vitro. The cellular responses to DA, attributable to the activation of somatodendritic D2/3 autoreceptors, were prolonged and did not completely wash out after pharmacological blockade of both types (A and B) of MAO. On the contrary, depression of the firing rate and membrane hyperpolarization induced by quinpirole (a direct D2 receptor agonist) were not affected by MAO inhibition. Furthermore, although the inhibition of DA reuptake by cocaine and nomifensine caused a short-term prolongation of DA responses, the combined inhibition of MAO A and B enzymes caused a long-term prolongation of DA effects. Moreover, the effects of DA were not largely prolonged during the simultaneous inhibition of MAO and the DA reuptake system. Interestingly, the actions of amphetamine were not clearly augmented by MAO inhibition. From the present data it is concluded that the termination of DA action in the brain is controlled mainly by MAO enzymes. This long-term prolongation of the dopaminergic responses suggests a substitutive therapeutic approach that uses MAO inhibitors and DA precursors in DA-deficient disorders in which continuous stimulation of the dopaminergic receptors is preferable.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065488      PMCID: PMC6573484     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.

Authors:  S P Butcher; I S Fairbrother; J S Kelly; G W Arbuthnott
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

2.  Actions of cocaine on central monoamine neurons: intracellular recordings in vitro.

Authors:  J Williams; M Lacey
Journal:  NIDA Res Monogr       Date:  1988

3.  The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1974-06       Impact factor: 4.030

4.  Effects of intrastriatal kainic acid injection on [3H]dopamine metabolism in rat striatal slices: evidence for postsynaptic glial cell metabolism by both the type A and B forms of monoamine oxidase.

Authors:  D D Schoepp; A J Azzaro
Journal:  J Neurochem       Date:  1983-05       Impact factor: 5.372

5.  The mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro.

Authors:  N B Mercuri; P Calabresi; G Bernardi
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

6.  Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.

Authors:  L G Hársing; E S Vizi
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

7.  Actions of cocaine on rat dopaminergic neurones in vitro.

Authors:  M G Lacey; N B Mercuri; R A North
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study.

Authors:  N B Mercuri; A Bonci; A Siniscalchi; A Stefani; P Calabresi; G Bernardi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.

Authors:  C J Fowler; M S Benedetti
Journal:  J Neurochem       Date:  1983-06       Impact factor: 5.372

10.  Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.

Authors:  S Kito; M Shimoyama; R Arakawa
Journal:  Jpn J Pharmacol       Date:  1986-01
View more
  7 in total

1.  Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Authors:  Michael B Gatch; Cynthia M Taylor; Elva Flores; Meghan Selvig; Michael J Forster
Journal:  Behav Pharmacol       Date:  2006-03       Impact factor: 2.293

Review 2.  Medical management of levodopa-associated motor complications in patients with Parkinson's disease.

Authors:  Joseph Jankovic; Mark Stacy
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Reversal of dopamine-mediated firing inhibition through activation of the dopamine transporter in substantia nigra pars compacta neurons.

Authors:  Daniela Aversa; Alessandro Martini; Ezia Guatteo; Antonio Pisani; Nicola Biagio Mercuri; Nicola Berretta
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

4.  Obesity attenuates D2 autoreceptor-mediated inhibition of putative ventral tegmental area dopaminergic neurons.

Authors:  Susumu Koyama; Masayoshi Mori; Syohei Kanamaru; Takuya Sazawa; Ayano Miyazaki; Hiroki Terai; Shinichi Hirose
Journal:  Physiol Rep       Date:  2014-05-02

5.  Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.

Authors:  Annalisa Nobili; Emanuele Claudio Latagliata; Maria Teresa Viscomi; Virve Cavallucci; Debora Cutuli; Giacomo Giacovazzo; Paraskevi Krashia; Francesca Romana Rizzo; Ramona Marino; Mauro Federici; Paola De Bartolo; Daniela Aversa; Maria Concetta Dell'Acqua; Alberto Cordella; Marco Sancandi; Flavio Keller; Laura Petrosini; Stefano Puglisi-Allegra; Nicola Biagio Mercuri; Roberto Coccurello; Nicola Berretta; Marcello D'Amelio
Journal:  Nat Commun       Date:  2017-04-03       Impact factor: 14.919

6.  PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.

Authors:  Graziella Madeo; Tommaso Schirinzi; Giuseppina Martella; E Claudio Latagliata; Francesca Puglisi; Jie Shen; Enza Maria Valente; Mauro Federici; Nicola B Mercuri; Stefano Puglisi-Allegra; Paola Bonsi; Antonio Pisani
Journal:  Mov Disord       Date:  2013-10-25       Impact factor: 10.338

7.  Obesity decreases excitability of putative ventral tegmental area GABAergic neurons.

Authors:  Susumu Koyama; Mari Kawaharada; Hiroki Terai; Masahiro Ohkurano; Masayoshi Mori; Syohei Kanamaru; Shinichi Hirose
Journal:  Physiol Rep       Date:  2013-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.